Business Wire

Shippeo Launches Shippeo AI, Turning Trusted Visibility Into Instant, Intelligent Action

6.11.2025 13:00:00 EET | Business Wire | Press release

Share

Shippeo, the leading provider of real-time transportation visibility (RTTV), revealed Shippeo AI today, at its Visibility Now! conference. This brand new intelligent layer of the Shippeo Platform delivers trusted visibility and instant action to empower the people behind global supply chains.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251106263715/en/

Alongside Shippeo AI, the company revealed a series of product enhancements: an all-new eCMR (Electronic Consignment Note) system; transformed Air Visibility; a deeper user experience for Finished Vehicle Logistics (FVL); and enhanced data accessibility and UX for the Shippeo platform.

This raft of innovations reinforces Shippeo’s position as the world’s most trusted multimodal visibility platform.

Shippeo AI, for people who keep the world moving… faster

Shippeo AI, the new intelligent layer embedded across the entire Shippeo platform, transforms trusted visibility into confident, real-time action.

Shippeo AI is powered by the industry’s most accurate, SLA-backed transportation visibility data, delivering reliable insights when they matter most.

Shippeo AI can be accessed via two main interfaces:

  • For customers in the heat of the action, who need fast answers to questions like “Why don’t I have an ETA?” they can simply ask in Sidekick, fromwherever they are in the Shippeo platform.
  • For those seeking to improve performance, analyze and dive deeper - for example to compare data quality for their top five carriers - in Workspace, they can find deep, interactive analysis to uncover root causes of disruptions, and recommend improvements.

At the core of Shippeo AI is the Agent Library, a collection of specialized AI agents; experts which draw on Shippeo’s trusted data for specific, high-value jobs. Shippeo AI’s agents can, for example, provide instant, detailed status for any shipment; help diagnose road data gaps, understand root causes, and identify fixes.

Furthermore, this is just the beginning. Future Shippeo agents will continue to help sector leaders solve the most difficult problems in supply chains, for example by going beyond insights to suggest autonomously-executed actions, combining human judgment with AI.

“We know the majority of supply chain organizations have yet to achieve measurable ROI from their AI initiatives,” says Shippeo’s CPO, Anand Medepalli. “This is why we’re resolutely focused on delivering ‘Useful AI’. Shippeo AI transforms the trusted visibility data you rely on into confident, intelligent action. It helps your teams move faster when they’re under pressure and focus their expertise where it matters most, so they can ultimately be more productive.”

More information about Shippeo AI is available here…

Also announced at Visibility Now! - eCMR, Air Visibility, FVL, new UX and foundational data quality

Alongside the launch of Shippeo AI, the company announced a range of new capabilities that tackle the day-to-day challenges that supply chain teams face.

First and foremost, Shippeo is also doubling down on the foundations of its already market-beating data quality, by making that data more accessible and intuitive than ever. Risks of pairing issues have been significantly reduced; more flexible pairing modes have been added; and we’ve made fewer data fields mandatory, again to free up more time for teams.

Other new product announcements empower customers to master new regulations, close visibility gaps, and deepen control over complex operations:

- Simplifying compliance with eCMR (Electronic Consignment Notes) - Shippeo’s new eCMR functionality builds compliance into your workflows - essential, considering the new international eCMR standard is currently being adopted by over 30 countries - whilst replacing paper processes with real-time, verifiable data.
- End-to-end visibility - The new Air Visibility expansion extends to the skies the same precision shippers expect on road and sea. Consolidating all air shipments into one single view, it automatically pulls transportation details from airlines, via Master Air Waybills.
- Deepening control in FVL (Finished Vehicle Logistics) – Shippeo has enhanced its Roll-on/Roll-off (RoRo) visibility solution, delivering unmatched tracking thanks to its connection with over 95% of the global RoRo fleet. A new in-app Vehicle Damage Report lets drivers capture time-stamped, geo-tagged evidence instantly, accelerating claims and improving delivery reliability from plant to dealer.
- Enhanced User Experience (UX) - The new Global Map offers a real-time, 360° view of logistics operations, providing visibility of any ocean vessel worldwide, simplifying the choice of the most efficient routes. Finally, enhanced ETA displays provide greater clarity and context, empowering proactive decision-making.

About Shippeo

Shippeo, a global leader in real-time multimodal transportation visibility (RTTV), is the only provider whose contractual SLAs guarantee success. Global shippers and logistics service providers trust Shippeo to give them the visibility they need to build resilient, sustainable, and customer-centric supply chains, thanks to market-leading data quality and unrivalled AI-powered ETA accuracy. Shippeo’s platform allows businesses to manage risks, anticipate disruptions, optimize cost and operational efficiency, and reduce transport-related greenhouse gas emissions. Our network integrates with over 228,000 carriers and 1,100 TMS, telematics and ELD systems, offering instant access to real-time tracking for 100 million shipments annually, across all transportation modes. Shippeo delivers exceptional service to hundreds of customers - including global brands such as AkzoNobel, Barilla, Carrefour, Coca-Cola HBC, L’Oréal, LVMH, Renault Group, Saint-Gobain and Yamaha - in over 150 countries.

For more information, visit www.shippeo.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20251106263715/en/

Contacts

Media Contact: James Martin, james.martin@shippeo.com, +33 7 61 54 35 50

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye